Skip to main content

Valink Therapeutics

London, United Kingdom

Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.

$11.8M raised
Oct 2025
Seed

Top Investors

Y CombinatorHoxton VenturesOxford Science EnterprisesredalpineOxonian Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Valink Therapeutics

How much funding has Valink Therapeutics raised?
Valink Therapeutics has raised $11.8M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Who are Valink Therapeutics's investors?
Valink Therapeutics's investors include Y Combinator, Hoxton Ventures, Oxford Science Enterprises, redalpine, Oxonian Ventures.
Where is Valink Therapeutics headquartered?
Valink Therapeutics is headquartered in London, United Kingdom.
What does Valink Therapeutics do?
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.
What stage is Valink Therapeutics at?
Valink Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Valink Therapeutics — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/valink-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2025). Valink Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/valink-therapeutics
Wikipedia (cite web)
{{cite web |title=Valink Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/valink-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .